Literature DB >> 21451211

Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis.

A Ya Sklyarov1, N B Panasyuk, I S Fomenko.   

Abstract

Development of ulcerative colitis was accompanied by the activation of iNOS/COX-2/5-LOX and increased contents of nitric oxide (NO), prostaglandin E₂ (PGE₂), and leukotriene B₄ (LTB₄). The following information was assessed: morphological changes, activity of nitric oxide-synthase, content of nitric oxide, and indexes of lipoperoxidation processes in the mucous membrane of the large intestine (MMLI). Colitis was induced in rats by intrarectal administration of 1 ml of 4% acetic acid. Aminoguanidine--selective inducible nitric oxide-synthase (iNOS) blocker, celecoxib--cyclooxygenase-2 (COX-2) inhibitor, indomethacin--non-selective COX inhibitor and AA-861--5-lipooxygenase (5-LOX) blocker were administered in 1 ml volumes per os 1 hour before and 24 hours after the intrarectal application of acetic acid. It was noticed that blockage of iNOS by aminoguanidine caused enhancement of cytoprotective mechanisms, reduction of iNOS activity and oxidative stress, and an increase in blood L-arginine level as compared to their respective indexes in colitis. Combined blockage of iNOS and COX-2 displayed additive character of their effect on the processes of lipoperoxidation and activity of iNOS. Combined blockage of iNOS, COX-2 and 5-LOX had a manifested cytoprotective effect under condition of ulcerative colitis and was accompanied by a sharp decline in NOS activity and oxidative stress. If each of these systems, iNOS/NO, COX-2/PGE₂ and 5-LOX/LTB₄ are simultaneously activated due to inflammation, they contribute to the destructive damage of the MMLI, development of oxidative stress, and affect components of the antioxidant protection system. The obtained results substantiate the relevance of treatment of the inflammatory processes with the use of medication capable of combined blockage of iNOS, COX-2, and 5-LOX.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451211

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  22 in total

Review 1.  Recent advances in understanding ulcerative colitis.

Authors:  Antonio Di Sabatino; Paolo Biancheri; Laura Rovedatti; Thomas Thornton Macdonald; Gino Roberto Corazza
Journal:  Intern Emerg Med       Date:  2011-11-09       Impact factor: 3.397

2.  Inflammatory bowel disease affects density of nitrergic nerve fibers in the mucosal layer of the canine gastrointestinal tract.

Authors:  Andrzej Rychlik; Slawomir Gonkowski; Marcin Nowicki; Jaroslaw Calka
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

3.  Temporal and spatial dependence of inflammatory biomarkers and suppression by fluvastatin in dextran sodium sulfate-induced rat colitis model.

Authors:  Masaharu Oishi; Katsuji Tokuhara; Hirokazu Miki; Yoshito Tanaka; So Yamaki; Masaki Kaibori; Katsuhiko Yoshizawa; Takashi Yuri; Emi Yoshigai; Mikio Nishizawa; Tadayoshi Okumura; A-Hon Kwon
Journal:  Dig Dis Sci       Date:  2014-04-30       Impact factor: 3.199

4.  Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis.

Authors:  Ramanpreet Kaur; Dhimant Desai; Shantu Amin; Kaisar Raza; Aman Bhalla; Pooja Yadav; Naveen Kaushal
Journal:  Mol Cell Biochem       Date:  2022-08-24       Impact factor: 3.842

5.  Sinapic Acid Ameliorates Acetic Acid-Induced Ulcerative Colitis in Rats by Suppressing Inflammation, Oxidative Stress, and Apoptosis.

Authors:  Mudassar Shahid; Mohammad Raish; Ajaz Ahmad; Yousef A Bin Jardan; Mushtaq Ahmad Ansari; Abdul Ahad; Khalid M Alkharfy; Ahmed L Alaofi; Fahad I Al-Jenoobi
Journal:  Molecules       Date:  2022-06-28       Impact factor: 4.927

6.  A COX/5-LOX Inhibitor Licofelone Revealed Anticonvulsant Properties Through iNOS Diminution in Mice.

Authors:  Borna Payandemehr; Mahsima Khoshneviszadeh; Bardia Varastehmoradi; Ramtin Gholizadeh; Taraneh Bahremand; Hossein Attar; Arash Bahremand; Ahmad Reza Dehpour
Journal:  Neurochem Res       Date:  2015-07-28       Impact factor: 3.996

7.  Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids.

Authors:  Juan Suárez; Yanina Romero-Zerbo; Lucia Márquez; Patricia Rivera; Mar Iglesias; Francisco J Bermúdez-Silva; Montserrat Andreu; Fernando Rodríguez de Fonseca
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation, Oxidative Stress and Apoptosis.

Authors:  Jia Yang; Xing-Xing Liu; Heng Fan; Qing Tang; Zhe-Xing Shou; Dong-Mei Zuo; Zhou Zou; Meng Xu; Qian-Yun Chen; Ying Peng; Shuang-Jiao Deng; Yu-Jin Liu
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

9.  Ethanol Extract of Antrodia camphorata Grown on Germinated Brown Rice Suppresses Inflammatory Responses in Mice with Acute DSS-Induced Colitis.

Authors:  Dong Ki Park; Hye-Jin Park
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

10.  Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients.

Authors:  Dorra Bouzid; Bochra Gargouri; Riadh Ben Mansour; Ali Amouri; Nabil Tahri; Saloua Lassoued; Hatem Masmoudi
Journal:  Saudi J Gastroenterol       Date:  2013 May-Jun       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.